Drugs for preventing lung cancer in healthy people (Q24248776)

Cochrane Database of Systematic Reviews

Europe PubMed Central

title

Drugs for preventing lung cancer in healthy people (English)

0 references

1 reference

4

0 references

Consol Serra

series ordinal

3

0 references

author name string

Magali Caraballoso

series ordinal

1

0 references

Montse Sacristan

series ordinal

2

0 references

publication date

22 April 2003

0 references

published in

0 references

cites work

Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141

The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141

The protective effect of beta-carotene and retinol on ventilatory function in an asbestos-exposed cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141

Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141

Effects of beta-carotene supplementation on cancer incidence by baseline characteristics in the Physicians' Health Study (United States).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141

A randomized trial of aspirin and beta-carotene among U.S. physicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141

Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141

Final report on the aspirin component of the ongoing Physicians' Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141

The effect of the synthetic retinoid etretinate on sputum cytology: results from a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141

Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141

Vitamin A and cancer prevention II: comparison of the effects of retinol and beta-carotene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141

Vitamin A and cancer prevention I: observations in workers previously exposed to asbestos at Wittenoom, Western Australia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141

The EUROSCAN Study. EUROSCAN Steering Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141

Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141

Randomized placebo-controlled trial of isotretinoin in chemoprevention of bronchial squamous metaplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141

Adjuvant treatment of stage I lung cancer with high-dose vitamin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141

Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141

A primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers in a general population: the SU.VI.MAX study--design, methods, and participant characteristics. SUpplementation en VItamin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141

Vitamin/mineral supplementation and cancer risk: international chemoprevention trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141

Serum retinol, beta-carotene, vitamin E, and selenium as related to subsequent cancer of specific sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141

Cancer chemoprevention and therapy by monoterpenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141

21 January 2018

Cancer chemoprevention

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141

Primary cancer prevention trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141

Chemoprevention strategies in lung carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141

Mortality by cause for eight regions of the world: Global Burden of Disease Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141

Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141

Co-carcinogenic effect of beta-carotene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141

Can dietary beta-carotene materially reduce human cancer rates?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141

Biology and chemoprevention of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141

Chemoprevention of cancer: a controversial and instructive story

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141

Chemoprevention strategies for non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141

Retinoids in chemoprevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141

Statistical design and monitoring of the carotene and retinol efficacy trial (CARET)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141

Lung cancer chemoprevention with retinol palmitate. Preliminary data from a randomized trial on stage Ia non small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141

CHEMOPREVENTION OF LUNG CANCER: The Rise and Demise of Beta-Carotene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141

Promoter Methylation and Silencing of the Retinoic Acid Receptor- Gene in Lung Carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141

Clinical trials in cancer prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141

7 January 2021

The CARET asbestos-exposed cohort: Baseline characteristics and comparison to other asbestos-exposed cohorts

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141

7 January 2021

Prevention of second primary tumours with etretinate in squamous cell carcinoma of the oral cavity and oropharynx. Results of a multicentric double-blind randomised study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141

7 January 2021

The alpha-tocopherol, beta-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance. The ATBC Cancer Prevention Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141

7 January 2021

"The SU.VI.MAX Study": a primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers. SUpplementation on VItamines et Minéraux AntioXydants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141

7 January 2021

Inhibition of oxidative DNA damage, 8-OHdG, and carbonyl contents in smokers treated with antioxidants (vitamin E, vitamin C, beta-carotene and red ginseng)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141

7 January 2021

Preliminary report: Findings from the aspirin component of the ongoing Physicians' Health Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141

7 January 2021

Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141

7 January 2021

Lung cancer and vitamin supplementation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141

7 January 2021

Baseline Characteristics of Participants in the Women's Health Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141

7 January 2021

Beta-Carotene, vitamin A, and lung cancer chemoprevention: results of an intermediate endpoint study.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141

7 January 2021

Beta-carotene and lung cancer: a case study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141

7 January 2021

Etretinate blood levels in monitoring of compliance and contamination in a chemoprevention trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141

7 January 2021

Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141

7 January 2021

Beta-carotene supplementation and incidence of cancer and cardiovascular disease: the Women's Health Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141

7 January 2021

Placebo-controlled trial of 13-cis-retinoic acid activity on retinoic acid receptor-beta expression in a population at high risk: implications for chemoprevention of lung cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141

7 January 2021

Chemoprevention of lung cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141

7 January 2021